Privacy Policy

FHL Therapeutics Website Privacy Policy


Forest Hills Partners (“us”, “we”, or “our”) operates https://fhltherapeutics.com/ (the “Website”).
We are committed to ensuring that your privacy is protected and this page informs you of our policies regarding the collection, use and disclosure of Personal Information we receive from users of the Website. If you are asked to provide information when using the Website, it will only be used in the ways described in this privacy policy.
By using the Site, you agree to the collection and use of information in accordance with this policy.



Information Collection


While using the Website, we may ask you to provide us with certain personally identifiable information. Personally identifiable information may include, but is not limited to your name, address, email address, contact number (“Personal Information”).
By using the Site, you agree to the collection and use of information in accordance with this policy.



Use of Information


We use this information in order to provide products and services, to enable certain functions on the Website and to understand your needs and provide you with a better service, and in particular for the following reasons:


• To complete order/s purchased via the Website, and to process your payments

• To improve our products and services we provide

• To customize the Website for you. Internal record keeping, and administrative purposes

• To contact you in response to specific enquiry



Cookies


Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer’s hard drive. Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Site.



Security


The security of your Personal Information is important to us, but remember the internet is not a secure medium. However, we take reasonable technical and organizational precautions to prevent the loss, misuse or alteration of your personal information.



Changes to This Privacy Policy


This Privacy Policy is effective as of December 1, 2023 and will remain in effect except with respect to any changes in its provisions in the future, which will be in effect immediately after being posted on this page. We reserve the right to make changes to this privacy policy from time to time and you should check this Privacy Policy periodically. Your continued use of the Website after we post any modifications to the Privacy Policy on this page will constitute your acknowledgment of the modifications and your consent to abide and be bound by the modified Privacy Policy.



Contact Us


If you have any questions about this Privacy Policy, please contact us at +852 2155 0487 or email us at info@foresthillslab.com.

Terms & Conditions

FHL Therapeutics Website Privacy Policy


Forest Hills Partners (“FHP”) owns and operates this website (https://fhltherapeutics.com/). (This document governs your relationship with our website. These Terms and Conditions (the “Terms”) contained herein on this webpage, shall govern your use of the website, including all pages within this website (the “Website”). The Terms apply in full force and effect to your use of the Website and by accessing the Website, you agree to be bound by the Terms contained herein in full. You must not use the Website, if you disagree with any part of the Terms.



Age Restriction


You must be at least 18 years of age to use the Website; by using the Website or agreeing to the Terms, you warrant and represent to us that you are at least 18 years of age.



Intellectual Property Rights


The intellectual property rights in all software and content (including photographic images) made available to you on or through the Website remains the property of FHP or its licensors and are protected by copyright laws and treaties around the world. All such rights are reserved by FHP and its licensors. You may store, print and display the content supplied solely for your own personal use. You are not permitted to publish, manipulate, distribute or otherwise reproduce, in any format, any of the content or copies of the content supplied to you or which appears on the Website nor may you use any such content in connection with any business or commercial enterprise.



Coockies


Cookies are files with small amount of data, which may include an anonymous unique identifier. Cookies are sent to your browser from a web site and stored on your computer’s hard drive. Like many sites, we use “cookies” to collect information. You can instruct your browser to refuse all cookies or to indicate when a cookie is being sent. However, if you do not accept cookies, you may not be able to use some portions of our Site.



Prohibitions


You are expressly and emphatically restricted from all of the following: publishing any the Website material in any media; selling, sublicensing and/or otherwise commercializing any the Website material transmit or distribute a virus, trojan, worm, logic bomb or any other material which is malicious, technologically harmful, in breach of confidence or in any way offensive or obscene; using the Website in any way that impacts user access to the Website; engaging in any data mining, data harvesting, data extracting or any other similar activity in relation to the Website, or while using the Website; send any unsolicited advertising or promotional material, commonly referred to as “spam”;
Breaching this provision would constitute a criminal offense and FHP will report any such breach to the relevant law enforcement authorities and disclose your identity to them.
We will not be liable for any loss or damage caused by a distributed denial-of-service attack, viruses or other technologically harmful material that may infect your computer equipment, computer programs, data or other proprietary material due to your use of the Website or to your downloading of any material posted on it, or on any the website linked to it



No Warranties


The Website is provided “as is,” with all faults, and FHP makes no express or implied representations or warranties, of any kind related to the Website or the materials contained on the Website. Additionally, nothing contained on the Website shall be construed as providing consult or advice to you.



General Conditions


We reserve the right to refuse service to anyone for any reason at any time



Intellectual Property Rights


The intellectual property rights in all software and content (including photographic images) made available to you on or through the Website remains the property of FHP or its licensors and are protected by copyright laws and treaties around the world. All such rights are reserved by FHL and its licensors. You may store, print and display the content supplied solely for your own personal use. You are not permitted to publish, manipulate, distribute or otherwise reproduce, in any format, any of the content or copies of the content supplied to you or which appears on the Website nor may you use any such content in connection with any business or commercial enterprise.



Disclaimer of Liability


In no event shall FHP, nor any of its officers, directors and employees, be liable to you for anything arising out of or in any way connected with your use of the Website, whether such liability is under contract, tort or otherwise, and FHP including its officers, directors and employees shall not be liable for any indirect, consequential or special liability arising out of or in any way related to your use of the Website.



Indemnity


You agree to indemnify, defend and hold harmless FHP, its directors, officers, employees, consultants, agents, and affiliates, from and against any and all liabilities, costs, demands, causes of action, damages and expenses (including reasonable attorney’s fees) arising out of or in any way related to your breach of any of the provisions of the Terms.



Variation


FHP shall have the right in its absolute discretion at any time and without notice to amend, remove or vary the Website and/or any page of the Website. You should check this page regularly to take notice of any changes we may have made to the Terms.



Invalidity


If any provision of the Terms is found to be unenforceable or invalid under any applicable law, such unenforceability or invalidity shall not render the Terms unenforceable or invalid as a whole, and such provisions shall be deleted without affecting the remaining provisions herein.



Complaints


We operate a complaint handling procedure which we will use to try to resolve disputes when they first arise, please let us know if you have any complaints or comments through +852 2155 0487 or info@foresthillslab.com.



Waiver


If you breach these conditions and we take no action, we will still be entitled to use our rights and remedies in any other situation where you breach the Terms.



Entire Agreement


The above terms, including any legal notices and disclaimers contained on the Website, constitute the entire agreement of the parties and supersede any and all preceding and contemporaneous agreements between you and FHP, and supersede all prior agreements and understandings with respect to the same.

Press Releases
News
Forest Hills Lab Enters Exclusive Worldwide Patent License Agreement to Incorporate FHL-101 for the Treatment of TBI

2024.08.05

PARAMUS, NEW JERSEY, UNITED STATES, August 5, 2024 /EINPresswire.com/ -- Forest Hills Lab (“FHL”), an innovative global life sciences company focused on regenerative medicine and medical aesthetics, announced it has entered into an agreement with the United States Department of Veterans Affairs (“VA”) and Rush University to acquire an exclusive worldwide license for Glyceryl Tribenzoate for traumatic brain injury (TBI).

The agreement grants FHL worldwide exclusive rights to develop, utilize and commercialize compounds in the use of Glyceryl Tribenzoate (GTB) as a potential treatment for TBI.

“We are delighted to enter into an exclusive license agreement with the VA and Rush University as we advance FHL-101, our novel small molecule drug through further clinical development to treat devastating neurological disorders,” said Dr. Shrijay Vijayan, FHL’s Chief Scientific Officer. “FHL-101 has demonstrated promising anti-inflammatory properties and has been shown to stimulate remyelination and provide neuroprotection in various preclinical studies. We are committed to our relationship with the VA and Rush and share the common goal of realizing FHL-101's clinical benefits, ultimately improving the lives of families and patients living with TBI.”

FHL-101 is currently under investigation as an oral treatment for neurodegenerative conditions such as Parkinson’s disease and traumatic brain injury. A small molecule new chemical entity (NCE) composed of GTB, FHL-101 has successfully completed a Phase 1 clinical study, demonstrating its tolerability and excellent safety profile and is currently being optimized for the initiation of a Phase 2 clinical trial.

Alex Yang, J.D., LL.M., Forest Hills Lab Chairman and CEO, added, “FHL and VA share the excitement around GTB’s potential as a treatment of neurodegenerative conditions, especially one as devastating as TBI. This strategic agreement further strengthens our position and expands our opportunities to address the unmet needs of these devastating neurodegenerative diseases.”

The agreement is subject to various commercial milestones in which royalty fees would be paid based on the development of the program.

About FHL-101 (Glyceryl Tribenzoate)
FHL-101 is a novel small molecule drug, composed of Glyceryl Tribenzoate (GTB), under investigation for oral treatment of neurodegenerative conditions, such as Parkinson’s Disease. FHL-101 promotes the generation of Glial cell Derived Neurotrophic Factor (GDNF), a key protein that supports neuron function, suppresses inflammation, and prevents neuronal death in Parkinson’s Disease and other neurodegenerative conditions. FHL-101 has successfully completed a Phase 1 placebo-controlled, double-blind study, demonstrating its tolerability and excellent safety profile.

About Traumatic Brain Injury
Traumatic Brain Injury refers to trauma caused by an external force, causing damage to the brain. TBI is a major cause of death and disability in the US, with nearly 70,000 deaths as a result of TBI-related injuries as per the Centers for Disease Control and Prevention (CDC) in the United States. There are currently no pharmaceutical therapies designed to meaningfully improve treatment outcomes.

About Forest Hills Lab
Forest Hills Lab is an innovative global life sciences company focused on regeneration and committed to improving well-being in our rapidly aging society. The therapeutics division of Forest Hills Lab is a clinical stage biopharmaceutical platform with seven potentially disease-modifying therapies for neurological conditions. Our compounds demonstrated promising outcomes in addressing various neurodegenerative disease pathways. Our lead compounds include FHL-101, which has recently completed a Phase 1 clinical trial, and FHL-301, which is preparing to enter a Phase 2 clinical trial in Parkinson’s. Our platform seeks partners to add candidates to our pipeline towards clinical-stage development, collaborating on its co-development and licensing-out possibilities.

About the U.S. Department of Veterans Affairs
The U.S. Department of Veterans Affairs (VA) is an agency of the United States Federal Government providing benefits and healthcare services to military veterans. The U.S. Department of Veterans Affairs collaborates with universities and its researchers to license VA-owned patents out to private sector firms, allowing the technology to be commercialized while collecting royalties.

About Mstone Partners
Forest Hills Lab’s largest shareholder is Mstone Partners, an incubator of biotech, healthcare and AI companies. Mstone founds, staffs, develops, and grows portfolio companies by building upon novel technology as well as human and investment capital. Mstone has also established several companies under its platform, managing a portfolio of drug development companies in a centralized, hub-and-spoke model.

 

 

List